Literature DB >> 23419889

Outcome after laparoscopic gastric bypass for super-super obese patients.

A Schwartz1, L Etchechoury, D Collet.   

Abstract

GOAL: The surgical treatment of the super-super obese (SSO), defined by a body mass index (BMI) superior or equal to 60 kg/m2, is difficult. The goal of this study was to evaluate the results of laparoscopic gastric bypass (LGBP) in this setting. PATIENTS AND METHODS: Between June 2005 and December 2011, 20 SSO patients underwent LGBP by one surgeon. Postoperative complications, weight loss, evolution of co-morbidities and quality of life were analyzed. The Bariatric Analysis and Reporting Outcome System (BAROS) was used to classify outcomes.
RESULTS: There were 15 women and five men (median age: 37.5 years). Median BMI was 63 kg/m2. Median duration of operation was 180 minutes. One patient was converted to laparotomy. Three complications occurred: one grade I, one grade II and one grade V. The median excess weight loss was 47.1% at 12 months, 55.3% at 24 months, 53.3% at 36 months and 55.3% at 48 months. Among the patients with a follow-up of at least 12 months (n=17), the median quality of life score was 1.75 and the median BAROS score was 5.75. Arterial hypertension and type II diabetes resolved or improved in all patients and sleep apnea resolved in almost half of patients (43%).
CONCLUSIONS: LGBP appears feasible and effective for SSO, both in terms of weight loss and improvement of co-morbidities and quality of life as well, with a low rate of postoperative complications.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23419889     DOI: 10.1016/j.jviscsurg.2013.01.001

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  8 in total

1.  Surgical management of super-super obese patients: Roux-en-Y gastric bypass versus sleeve gastrectomy.

Authors:  Raquel Gonzalez-Heredia; Lisa Sanchez-Johnsen; Valeria S M Valbuena; Mario Masrur; Melissa Murphey; Enrique Elli
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

2.  Outcome of Laparoscopic Adrenalectomy in Obese Patients.

Authors:  Diana Paun; Rodica Petris; Roxana Ganescu; Sorin Paun; Mihaela Vartic; Mircea Beuran
Journal:  Maedica (Buchar)       Date:  2015-09

Review 3.  Intragastric Balloon for Management of Severe Obesity: a Systematic Review.

Authors:  Ekua Yorke; Noah Jacob Switzer; Artan Reso; Xinhe Shi; Christopher de Gara; Daniel Birch; Richdeep Gill; Shahzeer Karmali
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

4.  Comparison of early outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy among patients with body mass index ≥ 60 kg/m2.

Authors:  Hassan Nasser; Tommy Ivanics; Oliver A Varban; Jonathan F Finks; Aaron Bonham; Amir A Ghaferi; Arthur M Carlin
Journal:  Surg Endosc       Date:  2020-06-22       Impact factor: 4.584

5.  One-Stage vs Two-Stage Laparoscopic Roux-en-Y Gastric Bypass in Obese Patients with Body Mass Index >55 Kg/m2; 5-YEAR FOLLOW UP.

Authors:  María Díaz-Tobarra; Norberto Cassinello Fernández; Pablo Jordá Gómez; Mohammad Nebih Nofal; Raquel Alfonso Ballester; Joaquín Ortega Serrano
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

6.  Weight loss outcomes and complications from bariatric surgery in the super super obese.

Authors:  Oscar K Serrano; Jonathan E Tannebaum; Lindsay Cumella; Jenny Choi; Pratibha Vemulapalli; W Scott Melvin; Diego R Camacho
Journal:  Surg Endosc       Date:  2015-08-25       Impact factor: 4.584

7.  Endoscopic Sleeve Gastroplasty (ESG) for High-Risk Patients, High Body Mass Index (> 50 kg/m2) Patients, and Contraindication to Abdominal Surgery.

Authors:  Renjie Li; Wilfried Veltzke-Schlieker; Andreas Adler; Maximilian Specht; Wael Eskander; Mahmoud Ismail; Harun Badakhshi; Manoel Passos Galvao; Ricardo Zorron
Journal:  Obes Surg       Date:  2021-04-27       Impact factor: 4.129

8.  Outcomes of Bariatric Surgery: Patients with Body Mass Index 60 or Greater.

Authors:  Raelina S Howell; Helen H Liu; Harika Boinpally; Meredith Akerman; Elizabeth Carruthers; Barbara M Brathwaite; Patrizio Petrone; Collin E M Brathwaite
Journal:  JSLS       Date:  2021 Apr-Jun       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.